Publicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (4)

2024

  1. Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 9, pp. 1889-1905

2023

  1. Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer

    Cancer research, Vol. 83, Núm. 19, pp. 3284-3304

2022

  1. A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer

    Cancer research, Vol. 82, Núm. 20, pp. 3673-3686

2021

  1. The ESR1 Mutations: From Bedside to Bench to Bedside

    Cancer Research